4D Molecular Therapeutics, Inc. revenue for the last year amounted to 37.00 k USD, the most of which — 37.00 k USD — came from its highest performing source at the moment, Genetic Medicines, the year earlier bringing 20.72 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought 4D Molecular Therapeutics, Inc. 37.00 k USD, and the year before that — 20.16 M USD.